Feature | Radiation Oncology | July 07, 2015

Patients who undergo radiation therapy have a 25-40 percent increased risk of follow-up urological procedures due to treatment complications

prostate cancer, surgery, radiation therapy, side effects, University of Toronto

July 7, 2015 - New study findings reveal that more complications occur in patients treated with radiation therapy versus surgery for prostate cancer.

Researchers from the University of Toronto presented their findings at the Canadian Urological Association annual meeting in Ottawa in June. The findings further suggest that prostate cancer patients who undergo radiation therapy have a 25-40 percent increased risk of requiring minimally invasive urologic procedures due to treatment complications. They analyzed more than 60,000 men between the ages of 65 and 79 who had either undergone a radical prostatectomy or radiation.

"One of the issues with radiation as opposed to surgery is that many of the side effects can occur later on, which can include rectal and bladder bleeding, whereas the side effects that come along with surgery only improve as time goes on," noted David Samadi, M.D., chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York City.

Why should patients choose surgery over radiation? For many prostate cancers, surgery is the optimal treatment path because it's the only option that gives the most accurate staging and grading of the cancer. On top of that, the prostate gland and surrounding lymph nodes are completely removed. The patient's prostate-specific antigen (PSA) will drop to undetectable levels.

"Moving forward, the patient will know they are cured from this particular cancer. If the cancer recurs, patients have other options ahead of them. I always reserve low dose radiation after surgery if needed," said Samadi.

Samadi's SMART Technique for Robotic Prostate Surgery measures each patient's individual success and recovery based on his "triple play" treatment philosophy. This philosophy equally measures three aspects of the patient's quality of life after surgery: cancer cure, and retention of sexual function and continence.

"Recovery is faster and side effects are almost eliminated. Radiation can be effective for select patients, but robotic prostate surgery is much less invasive with almost no long-term urological issues," stressed Samadi.

This study is a key indicator that each treatment for prostate cancer can have various outcomes. Experts have long debated surgery versus radiation, especially when it comes to treating prostate cancer. Over the past decade the marketplace has become flooded with new technologies for prostate cancer treatment. But the truth is for qualified patients, surgery remains the only option that gives an accurate staging of the cancer and in the hands of a skilled surgeon, the prostate can be removed with greater attention resulting in improved functional outcomes, decreased blood loss, and a shorter recovery.

For more information: www.prostatecancer911.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
Subscribe Now